These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7249253)
61. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice. Rauko P; Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Schott H; Fritzer-Szekeres M; Novotny L; Szekeres T Anticancer Res; 2003; 23(5A):3841-6. PubMed ID: 14666686 [TBL] [Abstract][Full Text] [Related]
62. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo. Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375 [TBL] [Abstract][Full Text] [Related]
63. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334 [TBL] [Abstract][Full Text] [Related]
64. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation. Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282 [TBL] [Abstract][Full Text] [Related]
65. [Cellular mechanism of the antileukemic action of quinoline dibromide]. Golenko OD; Paramonova TD; Nikolaeva TG Biull Eksp Biol Med; 1984 Jul; 98(7):59-61. PubMed ID: 6466833 [TBL] [Abstract][Full Text] [Related]
66. Effect of lithium on the myelosuppressive and chemotherapeutic activities of vinblastine. Cass CE; Turner AR; Selner M; Allalunis MJ; Tan TH Cancer Res; 1981 Mar; 41(3):1000-5. PubMed ID: 7459846 [TBL] [Abstract][Full Text] [Related]
67. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia. Chello PL; Sirotnak FM Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551 [TBL] [Abstract][Full Text] [Related]
68. Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]butyric acid. Camoutsis C; Catsoulacos D; Karayiann V; Papageorgiou A; Mourelatos D; Mioglou E; Kritsi Z; Nikolaropoulos S Cancer Detect Prev; 2001; 25(6):558-64. PubMed ID: 12132876 [TBL] [Abstract][Full Text] [Related]
69. Antileukemic effects of 5-(2-dimethylaminoethoxy)-7-oxo-7H-benzo(c) fluorene, substance VUFB 13 468, on L1210 and La leukemia. Pujman V; Cernochová S Neoplasma; 1981; 28(6):715-20. PubMed ID: 7339500 [TBL] [Abstract][Full Text] [Related]
70. Effect of dihydroxyanthraquinone on the response of a rat solid tumor to radiation therapy. Kimler BF; Reddy EK; Henderson SD; Glover RW; Scanlan MF Am J Clin Oncol; 1984 Apr; 7(2):141-4. PubMed ID: 6702717 [TBL] [Abstract][Full Text] [Related]
71. Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice. Mihich E; Kitano M Cancer Res; 1971 Dec; 31(12):1999-2003. PubMed ID: 5120297 [No Abstract] [Full Text] [Related]
72. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206 [TBL] [Abstract][Full Text] [Related]
73. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
74. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells. Kawalec M; Skórski T; Kawiak J Invest New Drugs; 1988 Sep; 6(3):169-72. PubMed ID: 3192382 [TBL] [Abstract][Full Text] [Related]
75. Antitumor interaction of short-course endostatin and ionizing radiation. Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167 [TBL] [Abstract][Full Text] [Related]
76. Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210. Osswald H; Frank N J Cancer Res Clin Oncol; 1990; 116(5):448-52. PubMed ID: 1699945 [TBL] [Abstract][Full Text] [Related]
77. Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice. Auletta AE; Gery AM; Mead JA Cancer Res; 1974 Jul; 34(7):1581-5. PubMed ID: 4833911 [No Abstract] [Full Text] [Related]
78. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice. Mihich E Cancer Res; 1969 Apr; 29(4):848-54. PubMed ID: 4887203 [No Abstract] [Full Text] [Related]
79. Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates. Sironi M; Canegrati MA; Romano M; Vecchi A; Spreafico F Cancer Treat Rep; 1984 Apr; 68(4):643-5. PubMed ID: 6713420 [TBL] [Abstract][Full Text] [Related]